Viewing Study NCT06256627


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-03-16 @ 7:10 PM
Study NCT ID: NCT06256627
Status: RECRUITING
Last Update Posted: 2024-02-13
First Post: 2024-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Maintenance Treatment of "ITIVA" in AML Patients
Sponsor: Henan Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Maintenance Treatment View
None Minor Residue Disease View
None Interferon-α-1b View
None Interleukin-2 View
None Thalidomide View
None Venentoclax View
None Azacitidine View
Keywords: